Radiopharmaceutical Imaging and Dosimetry (Rapid), LLC

🚀 We’re Hiring! Rapid is seeking a Medical Physicist for Radiopharmaceutical Therapies in support of our growing CRO services. Apply today and join us in advancing RPT and Dosimetry! Apply here: https://lnkd.in/e4grpNeu #Hiring #MedicalPhysics #Dosimetry #Radiopharmaceuticals #CareerOpportunity #JoinRapid #RemoteJob #RPT #JobOpening

📣 Are you at the #SNMMI Theranostics Conference? Don’t miss the CRO Panel Discussion tomorrow, November 5 at 5:00 PM! We’re proud to share that Rapid co-founder and Chief Science Officer Dr. Eric Frey will be joining as a panelist — diving into the evolving role of CROs in radiopharmaceutical clinical trials. 💡 Want to take the conversation further? Schedule a free online consultation with Dr. Frey to explore how Rapid’s quantitative imaging and dosimetry expertise can be of service to you! 👉 Book here: https://lnkd.in/eVTC_AHe #Theranostics #Radiopharmaceuticals #SNMMI #ClinicalResearch #Dosimetry #PrecisionMedicine

Advancing Precision in Targeted Alpha Therapy   We at Rapid are proud to have contributed dosimetry analysis for the preclinical evaluation of [212Pb]Pb-ADVC001, a novel PSMA-targeted alpha therapy for prostate cancer, recently published in The Journal of Nuclear Medicine - JNM (Sept 2025).   This study by AdvanCell demonstrates potent, selective tumor targeting and extended survival in preclinical models — marking an exciting step toward next-generation radiopharmaceutical therapies.   At Rapid (Radiopharmaceutical Imaging and Dosimetry, LLC), we specialize in accurate, patient-specific dosimetry that transforms data into actionable insight — enabling safer, more effective radiopharmaceutical development.   Read the full publication here: https://lnkd.in/eQSHH8Y5   #Radiopharmaceuticals #Dosimetry #PrecisionMedicine #AlphaTherapy #ProstateCancer #NuclearMedicine #Rapid

🌟 Are you a Research Scientist? Join our team! 🌟 We’re hiring a Research Scientist to drive innovation in radiopharmaceutical therapy (RPT), focusing on applied research, algorithm development, and collaborative innovation in imaging physics, dosimetry, and software tools. This role offers a unique chance to shape the future of cancer care in a dynamic and supportive environment. Apply at: https://lnkd.in/edJzDJFK #ResearchScientist #RadiopharmaceuticalTherapy #HealthcareInnovation #NowHiring

🚨 Listen to the latest Podcast Episode with Dr. Ana Kiess of Johns Hopkins Hospital The latest episode of RPT & Dosimetry with Dr. George Sgouros is now live on Spotify and YouTube! 🎧 🎧 Spotify: https://lnkd.in/gf-JqdhU 📺 YouTube: https://lnkd.in/g8Xg2pt2 #RPT #RadiopharmaceuticalTherapy #Dosimetry #PRRT #Theranostics #CancerTreatment #MSK #Podcast #NewEpisode #Spotify #YouTube #pluvicto PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) HCP

🎙️ New Episode Alert! Join Dr. George Sgouros for a compelling conversation with Dr. Ana Kiess , Physician and Associate Professor at Johns Hopkins Hospital as they reminesce about their times at Memorial Sloan Kettering Cancer Center, discuss the transformative impact of PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) HCP and the promising future of PSMA-targeted alpha-emitter therapies, anticipating FDA approval soon. Listen on Spotify: https://lnkd.in/emV4wEWN Watch on YouTube: https://lnkd.in/eZaBk_9v #RadiopharmaceuticalTherapy #CancerTreatment #MedicalInnovation #HealthcareResearch #JohnsHopkins #FDAApproval

🚨 Have you heard the latest Podcast Episode with Dr. Lisa Bodei of Memorial Sloan Kettering Cancer Center The latest episode of RPT & Dosimetry with Dr. George Sgouros is now live on Spotify and YouTube! 🎧 🔊 Listen now on Spotify or watch the full episode on YouTube to catch the full conversation. 🎧 Spotify: https://lnkd.in/e-bDgXdd 📺 YouTube: https://lnkd.in/egs4Gdhi #RPT #RadiopharmaceuticalTherapy #Dosimetry #PRRT #Theranostics #CancerTreatment #MSK #Podcast #NewEpisode #Spotify #YouTube

Exciting news! Rapid is proud to support the Precision Dosimetry Imaging Biomarker (PDIB) project with the Foundation for the National Institutes of Health (FNIH). Learn more here: https://lnkd.in/gTJgX9CM #Dosimetry #RadiopharmaceuticalTherapy #FNIH #RapidDosimetry #CancerTreatment

🎧 New Episode Alert! In the latest episode of RPT & Dosimetry with Dr. George Sgouros, Dr. Lisa Bodei nuclear medicine physician and theranostics specialist from Memorial Sloan Kettering Cancer Center joins Dr. George Sgouros to discuss her work in peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors. Dr. Bodei also shares insights into her journey from Europe to the U.S., and how dose and radio-sensitivity are critical to shaping the future of Radiopharmaceutical Therapy. Plus, a quick laugh as George blames his son, Denis (the producer), for everything. 😉 🎧 Listen now and don’t miss this engaging conversation! Spotify: https://lnkd.in/eTcnxXAv #RPT #RadiopharmaceuticalTherapy #PRRT #Theranostics #Dosimetry #CancerTreatment #MSK #Podcast

🚀 Another one! Rapid awarded a $2M NIH grant to develop a cloud-based quantitative SPECT reconstruction platform for radiopharmaceutical therapy (RPT). This platform will enhance dosimetry for therapeutic radionuclides, with a focus on alpha-emitters, improving treatment accuracy and advancing precision medicine. 🔗 Read more: https://lnkd.in/d5XYvuSK #RadiopharmaceuticalTherapy #SPECTImaging #NIHGrant #Dosimetry #PrecisionMedicine